[Classification of systemic vasculitides]

Area of Science:

• Rheumatology
• Immunology
• Internal Medicine

Context:

• Established classification systems for systemic vasculitides include the Chapel Hill nomenclature, ACR criteria, and Lie's classification.
• These systems have limitations, highlighting the need for refined diagnostic approaches.
• Antineutrophil cytoplasmic antibodies (ANCA) have emerged as a significant factor in vasculitis classification.

Purpose:

• To evaluate the impact of ANCA on distinguishing between different types of systemic vasculitis.
• To clarify the diagnostic utility of ANCA in differentiating medium-vessel from small-vessel vasculitides.

Summary:

• The acceptance of ANCA's role has improved the ability to distinguish vasculitis affecting medium-caliber vessels from those affecting small vessels.
• This distinction is critical for differentiating conditions like polyarteritis nodosa (medium-vessel vasculitis) from microscopic polyangiitis (small-vessel vasculitis).
• Polyarteritis nodosa typically involves medium-sized arteries, potentially causing vascular nephropathy and organ ischemia.
• Microscopic polyangiitis can manifest as glomerulonephritis and pulmonary capillaritis.

Impact:

• Enhanced diagnostic accuracy for systemic vasculitides.
• Improved understanding of the distinct pathologies and clinical manifestations of polyarteritis nodosa and microscopic polyangiitis.
• Facilitates more targeted treatment strategies based on precise vasculitis classification.